Novo Nordisk A/S (NVO)
44.34
-0.40
(-0.89%)
USD |
NYSE |
May 18, 12:37
Novo Nordisk Shareholders Equity (Quarterly) : 31.31B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| GSK Plc | 23.54B |
| Johnson & Johnson | 81.19B |
| Eli Lilly & Co. | 31.20B |
| Lexicon Pharmaceuticals, Inc. | 202.86M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.23B |
| Total Liabilities (Quarterly) | 54.92B |
| Debt to Equity Ratio | 0.7209 |
| Current Ratio | 0.7875 |
| Net Debt Paydown Yield | -1.02% |